Hohl Benjamin
CHIEF FINANCIAL OFFICER
CIK: 1882764
All Transactions
| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Oct 19, 2026 | Enliven Therapeutics, Inc. (ELVN) | S | 6,018 | $38.48 | $231,545.56 | View Details Filing |
| Oct 19, 2026 | Enliven Therapeutics, Inc. (ELVN) | M | 6,018 | $0.00 | $0.00 | View Details Filing |
| Oct 19, 2026 | Enliven Therapeutics, Inc. (ELVN) | M | 6,018 | $14.85 | $89,367.30 | View Details Filing |
| Sep 17, 2026 | Enliven Therapeutics, Inc. (ELVN) | S | 2,194 | $50.72 | $111,270.47 | View Details Filing |
| Sep 17, 2026 | Enliven Therapeutics, Inc. (ELVN) | M | 3,982 | $0.00 | $0.00 | View Details Filing |
| Sep 17, 2026 | Enliven Therapeutics, Inc. (ELVN) | S | 289 | $51.49 | $14,881.45 | View Details Filing |
| Sep 17, 2026 | Enliven Therapeutics, Inc. (ELVN) | M | 3,982 | $14.85 | $59,132.70 | View Details Filing |
| Sep 17, 2026 | Enliven Therapeutics, Inc. (ELVN) | S | 3,535 | $50.03 | $176,851.10 | View Details Filing |
| Aug 17, 2026 | Enliven Therapeutics, Inc. (ELVN) | S | 4,630 | $58.35 | $270,168.37 | View Details Filing |
| Aug 17, 2026 | Enliven Therapeutics, Inc. (ELVN) | S | 1,388 | $59.35 | $82,382.80 | View Details Filing |
17 more transactions available โ create a free account to see 12 months of history | ||||||